Johnson & Johnson’s Covid-19 vaccine candidate begins Phase 3 trials in the United States today,…
eabramovichSeptember 24, 2020
MassBiologics of UMass Medical School has entered into an agreement with PTC Therapeutics to manufacture…
eabramovichSeptember 23, 2020
A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves…
eabramovichSeptember 23, 2020
The Center for Integrated Management of Antimicrobial Resistance, a collaborative effort supported by Tufts University…
eabramovichSeptember 23, 2020
Developing the best possible cancer therapies is the driving force of Dana-Farber Cancer Institute, but…
eabramovichSeptember 22, 2020
To achieve the goal of eradicating malaria set by the World Health Organization (WHO)’s Global Malaria…
eabramovichSeptember 22, 2020
Excited to be the first patient in a novel clinical trial, Jon Woods is hoping…
eabramovichSeptember 21, 2020
In the last decade, cancer immunotherapies have demonstrated improved clinical outcomes in patients with a…
eabramovichSeptember 21, 2020
Scientists at the Massachusetts General Hospital (MGH) have developed a molecular imaging probe to reveal…
eabramovichSeptember 21, 2020
